In subsequent studies, we used the main catalytic domain of dipeptidyl peptidase of murine FAP α as a vaccine that contains abundant T-cell epitopes and B-cell epitopes, combined with curcumin lavage that inhibits the expression of IDO to relieve tumor immune tolerance, to treat mice implanted with melanoma cells. The gene discussed is FAP; the disease is neoplasm.